Beta-Blockers Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Clinical Trials
• Forums

The Effect of Beta-blocker on Chronotropic Response and Cardiorespiratory Fitness in Patients With Atrial Fibrillation
Condition:   Atrial Fibrillation Intervention:   Drug: Reduced dosage of beta-blocker Sponsor:   National Taiwan University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 18, 2022 Category: Research Source Type: clinical trials

Use of the oral beta blocker bisoprolol to reduce the rate of exacerbation in people with chronic obstructive pulmonary disease (COPD): a randomised controlled trial (BICS)
DiscussionThe demonstration that bisoprolol reduces the incidence of exacerbations would be relevant not only to patients and clinicians but also to healthcare providers, in the UK and globally.Trial registrationCurrent controlled trialsISRCTN10497306. Registered on 16 August 2018 (Source: Trials)
Source: Trials - April 14, 2022 Category: Research Source Type: clinical trials